Biotechnology

New patent for the Azurity drug KONVOMEP – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published in New patent for the Azurity drug KONVOMEP


Annual Drug Patent Expiration for KONVOMEP

Konvomep is a drug marketed by Azurity and included in one NDA. It is available from a single supplier. There are two patents protecting this drug.

This drug has four patent family members in four countries.

The generic ingredient in KONVOMEP is omeprazole; sodium bicarbonate. One registered supplier for this compound. Additional details are available on omeprazole; sodium bicarbonate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published in New patent for the Azurity drug KONVOMEP



Source link

Related Articles

Back to top button